CLINICAL_TRIALS
trial_result
· 2015-09-16
Clinical Trial Update: Fasitibant Intra-articular Injection in Patients With Symptomatic Osteoarthritis of the Knee [Phase 2]
Summary
A Phase 2 clinical trial evaluating intra-articular fasitibant for knee osteoarthritis has completed and results have been posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Menarini Group | Conditions: Knee Osteoarthritis | Phase 2 | Status: COMPLETED | Results posted: 2015-09-16